Document Detail

Failure of superoxide dismutase and catalase to alter size of infarction in conscious dogs after 3 hours of occlusion followed by reperfusion.
MedLine Citation:
PMID:  3698229     Owner:  NLM     Status:  MEDLINE    
Superoxide dismutase (SOD) and catalase (CAT), enzymes that degrade superoxide anion and hydrogen peroxide, respectively, reduce size of infarction in anesthetized, open-chest dogs subjected to coronary occlusion followed by reperfusion. To evaluate potential protective effects of these enzymes in conscious animals, three groups of dogs were instrumented at sterile surgery with a hydraulic occluder on the left circumflex (LCX) coronary artery, sonomicrometers to measure regional wall thickness, and catheters to monitor arterial and left ventricular pressures. Ten to 14 days after surgery, the animals were sedated with morphine sulfate (0.5 mg/kg). The LCX artery was occluded for 3 hr by inflation of the hydraulic cuff. Infusions of SOD (n = 7), CAT (n = 6), or saline (control group, n = 7) were begun 15 min before reperfusion and lasted for 45 min of reperfusion. The doses of SOD and CAT were 5 mg/kg, dissolved in 60 ml of saline, and infused at a rate of 1 ml/min. Myocardial blood flow was measured with tracer-labeled microspheres (15 micron diameter) before occlusion, after 5 to 10 min of occlusion, after 150 min of occlusion, and 5 to 10 min after reperfusion. Size of infarction was measured 24 hr later by dual-perfusion staining with Evans blue and triphenyl tetrazolium. Size of infarction (expressed as a percentage of area at risk) did not differ significantly among the three groups: control, 32 +/- 17% (mean +/- SD); SOD, 38 +/- 17%; CAT, 27 +/- 17%. Hemodynamic parameters and myocardial blood flows (measured before infusion of any agents) were not significantly different among the three groups. Serum SOD levels in SOD-treated dogs were 19 +/- 2 micrograms/ml at the onset of reperfusion and 29 +/- 3 micrograms/ml at the end of the infusion. Blood assays collected after infusion showed a monoexponential decay of SOD levels with a half-life of 22 +/- 6 min. We conclude that myocardial protection by SOD or CAT is model dependent. In conscious dogs subjected to 3 hr of coronary occlusion followed by reperfusion, SOD and CAT failed to alter size of infarction.
K P Gallagher; A J Buda; D Pace; R A Gerren; M Shlafer
Related Documents :
16181879 - Multiple treatment approach to limit cardiac ischemia-reperfusion injury.
10211019 - Effects of halothane, enflurane, isoflurane, sevoflurane and desflurane on myocardial r...
9096919 - Prompt improvement of left ventricular function and preservation of topography with com...
1700219 - Delay of occurrence of reperfusion-induced ventricular fibrillation in the isolated rat...
12658209 - Hyperoxia elicits myocardial protection through a nuclear factor kappab-dependent mecha...
6479219 - Beneficial effects of nafazatrom on ischemic reperfused myocardium.
22104679 - Decreasing prevalence but increasing importance of left ventricular dysfunction and reo...
15707079 - Congestive heart failure: new paradigms and therapeutic targets.
17532959 - Results of a multicenter clinical trial with the thoratec implantable ventricular assis...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Circulation     Volume:  73     ISSN:  0009-7322     ISO Abbreviation:  Circulation     Publication Date:  1986 May 
Date Detail:
Created Date:  1986-05-27     Completed Date:  1986-05-27     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0147763     Medline TA:  Circulation     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1065-76     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Arterial Occlusive Diseases / drug therapy,  pathology*,  physiopathology
Blood Flow Velocity / drug effects
Catalase / blood,  therapeutic use*
Collateral Circulation / drug effects
Hemodynamics / drug effects
Myocardial Infarction / drug therapy,  pathology*,  physiopathology
Superoxide Dismutase / blood,  therapeutic use*
Time Factors
Grant Support
Reg. No./Substance:
EC; EC Dismutase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Therapy with cyclosporine in experimental murine myocarditis with encephalomyocarditis virus.
Next Document:  Protective effects of N-2-mercaptopropionyl glycine against myocardial reperfusion injury after neut...